March 7, 2021
Purdue Chemical Engineering-affiliated startup awarded NSF funding to advance ARDS treatment technologies
Spirrow Therapeutics, a startup cofounded by Purdue chemical engineers, was recently awarded a $256,000 Small Business Technology Transfer (STTR) Phase I grant from the National Science Foundation (NSF). The project, Polymer Surfactant Therapy for Acute Respiratory Distress Syndrome (COVID-19), will be conducted in partnership between Spirrow Therapeutics and the laboratory of Professor You-Yeon Won in the Davidson School of Chemical Engineering at Purdue University.